These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16381049)
1. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety. Lee D; Lee K; Cai XF; Dat NT; Boovanahalli SK; Lee M; Shin JC; Kim W; Jeong JK; Lee JS; Lee CH; Lee JH; Hong YS; Lee JJ Chembiochem; 2006 Feb; 7(2):246-8. PubMed ID: 16381049 [No Abstract] [Full Text] [Related]
2. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin]. Liao ZY; Zhen YS Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116 [No Abstract] [Full Text] [Related]
3. Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin. McErlean CS; Proisy N; Davis CJ; Boland NA; Sharp SY; Boxall K; Slawin AM; Workman P; Moody CJ Org Biomol Chem; 2007 Feb; 5(3):531-46. PubMed ID: 17252137 [TBL] [Abstract][Full Text] [Related]
4. Rational biosynthetic engineering for optimization of geldanamycin analogues. Kim W; Lee D; Hong SS; Na Z; Shin JC; Roh SH; Wu CZ; Choi O; Lee K; Shen YM; Paik SG; Lee JJ; Hong YS Chembiochem; 2009 May; 10(7):1243-51. PubMed ID: 19308924 [TBL] [Abstract][Full Text] [Related]
5. New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus. Wu CZ; Moon AN; Jang JH; Lee D; Kang SY; Park JT; Ahn JS; Hwang BY; Kim YH; Lee HS; Hong YS J Antibiot (Tokyo); 2011 Jun; 64(6):461-3. PubMed ID: 21448187 [No Abstract] [Full Text] [Related]
6. The missing C-17 O-methyltransferase in geldanamycin biosynthesis. Yin M; Lu T; Zhao LX; Chen Y; Huang SX; Lohman JR; Xu LH; Jiang CL; Shen B Org Lett; 2011 Jul; 13(14):3726-9. PubMed ID: 21682254 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents. Chiosis G; Caldas Lopes E; Solit D Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024 [TBL] [Abstract][Full Text] [Related]
8. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731 [TBL] [Abstract][Full Text] [Related]
9. [Hsp90: how a chaperone becomes a pharmacological target]. Jacquemin-Sablon A Bull Cancer; 2003 Nov; 90(11):935-6. PubMed ID: 14706894 [No Abstract] [Full Text] [Related]
10. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition. Patel K; Piagentini M; Rascher A; Tian ZQ; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R Chem Biol; 2004 Dec; 11(12):1625-33. PubMed ID: 15610846 [TBL] [Abstract][Full Text] [Related]
11. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of macbecin as an Hsp90 inhibitor. Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975 [TBL] [Abstract][Full Text] [Related]
14. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703 [TBL] [Abstract][Full Text] [Related]
15. Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions. Andrus MB; Meredith EL; Simmons BL; Soma Sekhar BB; Hicken EJ Org Lett; 2002 Oct; 4(20):3549-52. PubMed ID: 12323066 [TBL] [Abstract][Full Text] [Related]
16. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors. Zhang MQ; Gaisser S; Nur-E-Alam M; Sheehan LS; Vousden WA; Gaitatzis N; Peck G; Coates NJ; Moss SJ; Radzom M; Foster TA; Sheridan RM; Gregory MA; Roe SM; Prodromou C; Pearl L; Boyd SM; Wilkinson B; Martin CJ J Med Chem; 2008 Sep; 51(18):5494-7. PubMed ID: 18800759 [TBL] [Abstract][Full Text] [Related]
18. Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin. Bae Y; Buresh RA; Williamson TP; Chen TH; Furgeson DY J Control Release; 2007 Sep; 122(1):16-23. PubMed ID: 17651857 [TBL] [Abstract][Full Text] [Related]
19. Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Ochel HJ; Eichhorn K; Gademann G Cell Stress Chaperones; 2001 Apr; 6(2):105-12. PubMed ID: 11599571 [No Abstract] [Full Text] [Related]
20. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP Cell; 1997 Apr; 89(2):239-50. PubMed ID: 9108479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]